首页> 中文期刊>中国继续医学教育 >胺碘酮和贝那普利联合用药治疗阵发性心房颤动的临床疗效分析

胺碘酮和贝那普利联合用药治疗阵发性心房颤动的临床疗效分析

     

摘要

目的:观察分析两组患者的治疗效果及发生不良反应的情况。方法对照组患者使用胺碘酮进行药物治疗,实验组患者使用胺碘酮联合贝那普利联合药物治疗,做统计学对比。结果经过两种药物治疗,实验组患者治疗的有效率高达93.75%,对照组患者治疗的有效率为78.13%,且治疗后实验组患者心房内径小于对照组,两组患者治疗效果差异显著(P<0.05),差异具有统计学意义。结论使用胺碘酮联合贝那普利治疗阵发性心房颤动患者临床疗效显著,且治疗后患者未发生其他严重不良反应。%ObjectiveTo analysis the clinical effect and adverse effect of amiodarone combined with benazepril to the patients with paroxysmal atrial fibrillation. Methods The patients of control group were treated with amiodarone, the experimental group patients were treated with amiodarone combined with benazepril. The results were made statistical analysis.ResultsThe effective rate of the experimental group was 93.75% after treatment, the control group was 78.13%, and the atrial diameter of experimental group patients were less than that of the control group, the difference of the effects in two groups was signiifcant (P<0.05).Conclusion The clinical effect on amiodarone and benazepril combination treatment to paroxysmal atrial ifbrillation is obvious, there is no serious adverse effect after treatment. It is worthy to be promoted in clinic.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号